InVivoPlus anti-mouse CD8alpha

Catalog number: BP0061_100mg
Brand: Bio X Cell
Packing: 100 mg
Other sizes: Other sizes available
Price: € 3522.00
Expected delivery time: 7 days

Product specifications for - InVivoPlus anti-mouse CD8alpha

Promotion: The price displayed is only for academic or non-profit organizations. Please contact our helpdesk for regular prices.
Product group: Antibodies
Category: Primary Antibodies
Application: Other Application
Species: Mouse
Host: Rat
Clonality: Monoclonal
Isotype: IgG2b Kappa
Molecular weight: 150 kDa
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Concentration: 2-10 mg/ml
Scientific information: 
Clone ID: 2.43
Related products: 
Related products: Recommended Isotype Control(s): InVivoPlus rat IgG2b I sotype control (BP0090)
Recommended Dilution Buffer: InVivoPure pH 7.0 Dilution Buffer (IP0070)
Additional information: 
Synonyms: 2,43; 2.43; BP0061; CD8 alpha; CD8A; p32; MAL; Leu2; CD8; T8 T-cell antigen; T-lymphocyte differentiation antigen T8/Leu-2; T-cell surface glycoprotein CD8 alpha chain; T-cell antigen Leu2; T cell co-receptor; OKT8 T-cell antigen; Leu2 T-lymphocyte antigen; CD8 antigen, alpha polypeptide (p32); CD8a molecule; BioXCell
Moynihan KD, Opel CF, Szeto GL, et al. Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses. Nat Med. 2016;22(12):1402-1410. Read more
Vanpouille-box C, Diamond JM, Pilones KA, et al. TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity. Cancer Res. 2015;75(11):2232-42. Read more
Coffelt SB, Kersten K, Doornebal CW, et al. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature. 2015;522(7556):345-348. Read more
Twyman-saint victor C, Rech AJ, Maity A, et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature. 2015;520(7547):373-7. Read more
Yamada DH, Elsaesser H, Lux A, et al. Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infection. Immunity. 2015;42(2):379-390. Read more
Voron T, Colussi O, Marcheteau E, et al. VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors. J Exp Med. 2015;212(2):139-48. Read more
Van der jeught K, Joe PT, Bialkowski L, et al. Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity. Oncotarget. 2014;5(20):10100-13. Read more
Végran F, Berger H, Boidot R, et al. The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells. Nat Immunol. 2014;15(8):758-66. Read more
Deberge MP, Ely KH, Enelow RI. Soluble, but not transmembrane, TNF-α is required during influenza infection to limit the magnitude of immune responses and the extent of immunopathology. J Immunol. 2014;192(12):5839-51. Read more
Deng L, Liang H, Burnette B, et al. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest. 2014;124(2):687-95. Read more